Spirepoint Private Client, LLC Biogen Inc. Transaction History
Spirepoint Private Client, LLC
- $705 Billion
- Q2 2024
A detailed history of Spirepoint Private Client, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Spirepoint Private Client, LLC holds 1,349 shares of BIIB stock, worth $277,206. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,349
Previous 1,349
-0.0%
Holding current value
$277,206
Previous $291 Million
7.51%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.41 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.36 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.99 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.46 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.17 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $29.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...